HANOI: After a robust five‑week rally to start the year, Vietnam's stock market slipped into its first correction phase last ...
Despite new methodologies and flexible regulatory pathways, CNS biopharmaceuticals still face significant safety assessment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results